Atlas Trials

High-Risk Acute Myeloid Leukemia

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-Risk Acute Myeloid Leukemia

RecordFirmDate
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia (NCT05237258)Massachusetts General Hospital2022-06-01
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT (NCT05066958)Federal Research Institute of Pediatric Hematology, Oncology and Immunology2021-09-16
QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML (NCT03365661)Masonic Cancer Center, University of Minnesota2018-10-30
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT02861417)M.D. Anderson Cancer Center2016-08-05
CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML (NCT03384212)Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2016-08-01
CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML (NCT03384225)Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2016-08-01
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia (NCT01696084)Jazz Pharmaceuticals2012-12-13

Track High-Risk Acute Myeloid Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.